Aerion Bioscience’s Post

View organization page for Aerion Bioscience, graphic
Aerion Bioscience

28 followers

Aerion Bioscience BV Announces Groundbreaking Partnership with Rejuve.Bio to Transform Lung Cancer Screening We are proud to announce a strategic collaboration with Rejuve.Bio, a leading innovator in AI biotechnology. This partnership is set to revolutionize early lung cancer screening by integrating state-of-the-art AI with non-invasive diagnostic technologies. Together, we aim to significantly enhance early detection rates, offering new hope in the global battle against the leading cause of cancer-related deaths. In an era dominated by the urgent need for efficient and early cancer detection methods, Aerion Bioscience BV and Rejuve.Bio are committed to combining their expertise to confront this challenge. By leveraging Aerion's groundbreaking lung cancer screening platform and Rejuve.Bio's next-level AI and data analysis capabilities, this collaboration targets the development of a highly sensitive, non-invasive screening technology. This innovative approach aims to overcome the limitations of current screening methods, such as low-dose CT scans and blood tests, and to improve lung cancer companion diagnostics, identifying patients who would benefit most from specific treatments. Dr. Axel Schumacher, CEO of Aerion Bioscience BV, expressed his enthusiasm about the collaboration: "Uniting Aerion's biomarker panel with Rejuve Bio's pioneering neural-symbolic AI marks the beginning of a new era in lung cancer detection. Our joint endeavor is dedicated to redefining the standards for early detection and treatment, aiming to significantly improve patient outcomes." Echoing the excitement, Kennedy Schaal, CEO of Rejuve.Bio, highlighted the partnership's potential impact: "This collaboration leverages our AI biotechnology expertise with Aerion's innovative lung cancer screening technology. It's a significant step forward in our mission to extend human healthspan and save lives through early detection." The collaboration between Aerion Bioscience BV and Rejuve.Bio sets a new benchmark in the field of lung cancer screening, offering a cost-effective, non-invasive solution that reduces false positives and unnecessary medical interventions. Our joint efforts are not just about transforming cancer care; they symbolize a broader commitment to enhancing human healthspan, ensuring that early, accurate detection is accessible to all, and extending both the quality and duration of life. As part of our exciting journey, Aerion Bioscience BV is delighted to engage with the community and stakeholders. We invite you to follow our progress, engage with our stories, and join a movement dedicated to pioneering the future of global health in the fight against lung cancer. Together, we are not merely pursuing a breakthrough; we are setting the stage for a healthier future for millions around the globe. See here Rejuve.Bio's new crowdfunding campaign: https://lnkd.in/eFEng_zJ

Learn about Rejuve.Bio - Netcapital

Learn about Rejuve.Bio - Netcapital

netcapital.com

To view or add a comment, sign in

More Relevant Posts

Aerion Bioscience

28 followers

View Profile

Explore topics